Cargando…

Systematic Review of Inhaled Bronchodilator and Corticosteroid Therapies in Infants with Bronchopulmonary Dysplasia: Implications and Future Directions

BACKGROUND: There is much debate surrounding the use of inhaled bronchodilators and corticosteroids for infants with bronchopulmonary dysplasia (BPD). OBJECTIVE: The objective of this systematic review was to identify strengths and knowledge gaps in the literature regarding inhaled therapies in BPD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clouse, Brian J., Jadcherla, Sudarshan R., Slaughter, Jonathan L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4740433/ https://www.ncbi.nlm.nih.gov/pubmed/26840339 http://dx.doi.org/10.1371/journal.pone.0148188

Ejemplares similares

Inhaled Bronchodilator Use for Infants with Bronchopulmonary Dysplasia
por: Slaughter, Jonathan L, et al.
Publicado: (2014)

Utilization of Inhaled Corticosteroids for Infants with Bronchopulmonary Dysplasia
por: Slaughter, Jonathan L., et al.
Publicado: (2014)

Bronchodilator responsiveness and dysanapsis in bronchopulmonary dysplasia
por: Nelin, Leif D., et al.
Publicado: (2022)

Inhaled bronchodilator exposure in the management of bronchopulmonary dysplasia in hospitalized infants
por: Euteneuer, Joshua C., et al.
Publicado: (2020)

Use of inhaled corticosteroids for the prevention and/or treatment of bronchopulmonary dysplasia in preterm infants: a systematic review protocol
por: Shinwell, Eric S., et al.
Publicado: (2015)

The role of inhaled and/or nasal corticosteroids on the bronchodilator response
por: Lee, Ju Kyung, et al.
Publicado: (2010)

Use of Inhaled Iloprost in an Infant With Bronchopulmonary Dysplasia and Pulmonary Artery Hypertension
por: Hwang, Seung-Kyung, et al.
Publicado: (2009)

Corticosteroids for the prevention of bronchopulmonary dysplasia in preterm infants: a network meta-analysis
por: Zeng, Linan, et al.
Publicado: (2018)

Association of the Respiratory Severity Score with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension in Infants Born Extremely Preterm
por: Kielt, Matthew, et al.
Publicado: (2023)

Role of Postnatal Corticosteroids in the Treatment or Prevention of Bronchopulmonary Dysplasia
por: Bulbul, Ali, et al.
Publicado: (2023)

Present and Future of Bronchopulmonary Dysplasia
por: Bonadies, Luca, et al.
Publicado: (2020)

Inhaled nitric oxide in premature infants for preventing bronchopulmonary dysplasia: a meta-analysis
por: Zheng, Yi, et al.
Publicado: (2023)

Effect of allergic phenotype on treatment response to inhaled bronchodilators with or without inhaled corticosteroids in patients with COPD
por: Cheng, Shih-Lung, et al.
Publicado: (2017)

Pharmacotherapy for Pulmonary Hypertension in Infants with Bronchopulmonary Dysplasia: Past, Present, and Future
por: Fike, Candice D., et al.
Publicado: (2023)

Pulmonary hypertension in infants with bronchopulmonary dysplasia
por: Kim, Gi Beom
Publicado: (2010)

Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant
por: Rivera, Lidys, et al.
Publicado: (2016)

Inhaled nitric oxide for a severe respiratory syncytial virus infection in an infant with bronchopulmonary dysplasia
por: Leclerc, F., et al.
Publicado: (1994)

Biomarkers associated with bronchopulmonary dysplasia/mortality in premature infants
por: Balena-Borneman, Jessica, et al.
Publicado: (2016)

Evaluating the use of corticosteroids in preventing and treating bronchopulmonary dysplasia in preterm neonates
por: Olaloko, Oreoluwa, et al.
Publicado: (2018)

Circulating Endothelial Progenitor Cells Decrease in Infants with Bronchopulmonary Dysplasia and Increase after Inhaled Nitric Oxide
por: Qi, Yuanyuan, et al.
Publicado: (2013)

Pulmonary Hypertension in Preterm Infants With Bronchopulmonary Dysplasia
por: An, Hyo Soon, et al.
Publicado: (2010)

Nutrition of preterm infants in relation to bronchopulmonary dysplasia
por: Wemhöner, Andreas, et al.
Publicado: (2011)

Vitamin D and bronchopulmonary dysplasia in preterm infants
por: Joung, K E, et al.
Publicado: (2016)

An Innovative Model of Bronchopulmonary Dysplasia in Premature Infants
por: Zhang, Xiaoyue, et al.
Publicado: (2020)

Disease Phenotyping of Infants with Severe Bronchopulmonary Dysplasia
por: Mandell, Erica, et al.
Publicado: (2020)

In-hospital Outcomes of Premature Infants with Severe Bronchopulmonary Dysplasia
por: Jackson, Wesley, et al.
Publicado: (2017)

Airway administration of corticosteroids for prevention of bronchopulmonary dysplasia in premature infants: a meta-analysis with trial sequential analysis
por: Zhang, Zhi-Qun, et al.
Publicado: (2017)

A clinical study on plasma biomarkers for deciding the use of adjuvant corticosteroid therapy in bronchopulmonary dysplasia of premature infants
por: Zhu, Haiyan, et al.
Publicado: (2021)

Assessment of Corticosteroid Therapy and Death or Disability According to Pretreatment Risk of Death or Bronchopulmonary Dysplasia in Extremely Preterm Infants
por: Jensen, Erik A., et al.
Publicado: (2023)

Systemic postnatal corticosteroid use for the prevention of bronchopulmonary dysplasia and its relationship to early neurodevelopment in extremely preterm infants
por: Esterman, Emilia, et al.
Publicado: (2023)

Long-acting bronchodilators with or without inhaled corticosteroids and 30-day readmission in patients hospitalized for COPD
por: Bishwakarma, Raju, et al.
Publicado: (2017)

Replacing nebulizers by MDI-spacers for bronchodilator and inhaled corticosteroid administration: Impact on the utilization of hospital resources
por: Alhaider, S.A., et al.
Publicado: (2014)

Inhaled Bronchodilators and Corticosteroids in the Management of Bronchiolitis Obliterans due to Allogenic Hematopoietic Stem Cell Transplantation
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2022)

The Pandemic Allocation of Ventilators Model Penalizes Infants with Bronchopulmonary Dysplasia
por: Sundaram, Anupama, et al.
Publicado: (2023)

Genetic Variation in CRHR1 is Associated with Short-Term Respiratory Response to Corticosteroids in Preterm Infants at risk for Bronchopulmonary Dysplasia
por: Lewis, Tamorah, et al.
Publicado: (2018)

Initial respiratory management in preterm infants and bronchopulmonary dysplasia
por: López, Ester Sanz, et al.
Publicado: (2011)

Association between anemia and bronchopulmonary dysplasia in preterm infants
por: Duan, Jun, et al.
Publicado: (2016)

Evidence for the Management of Bronchopulmonary Dysplasia in Very Preterm Infants
por: Muehlbacher, Tobias, et al.
Publicado: (2021)

Association between probiotics and bronchopulmonary dysplasia in preterm infants
por: Qu, Yangming, et al.
Publicado: (2021)

Risk Factors for Tracheobronchomalacia in Preterm Infants With Bronchopulmonary Dysplasia
por: Su, Ya-Ting, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rn6a3svd6t3aa4fqcpop2kv1hi